A Favipiravir-induced Fever in a Patient with COVID-19.
Intern Med
; 59(22): 2951-2953, 2020.
Article
in English
| MEDLINE | ID: covidwho-941724
ABSTRACT
We herein report the first case of a fever induced by favipiravir, a potential coronavirus disease 2019 therapeutic drug. An 82-year-old man diagnosed with bilateral pneumonia was transferred to our hospital following a positive severe acute respiratory syndrome coronavirus 2 polymerase chain reaction test. He was treated with compassionate use of favipiravir. Both his oxygen demand and fever gradually improved after admission; however, his fever relapsed, and the C-reactive protein (CRP) levels increased on day 7. We diagnosed his fever as being favipiravir-induced. The fever resolved a few days after favipiravir discontinuation, demonstrating the accuracy of the diagnosis. This case revealed that favipiravir can induce a fever.
Keywords
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
Pneumonia, Viral
/
Pyrazines
/
Coronavirus Infections
/
Fever
/
Betacoronavirus
/
Amides
Type of study:
Case report
/
Observational study
Limits:
Humans
/
Male
Language:
English
Journal:
Intern Med
Journal subject:
Internal Medicine
Year:
2020
Document Type:
Article
Affiliation country:
Internalmedicine.5394-20
Similar
MEDLINE
...
LILACS
LIS